Granules India informs about press release

18 Apr 2019 Evaluate

Granules India has informed about submission of a copy of Press Release issued by the Company for receiving the approval from US FDA for the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of the company.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

579.70 6.20 (1.08%)
17-Dec-2025 15:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.00
Dr. Reddys Lab 1272.55
Cipla 1496.30
Zydus Lifesciences 917.95
Lupin 2111.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×